Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-4590317
  • Global Intrapartum Device Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: March 2017 | Report Code: HME-4590317

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Intrapartum period is the time period from the onset of labor to the end of the third stage of labor. Intrapartum devices such as monitors are used at the time pregnancy, delivery and labor to record   strength of the uterus contraction and heart rate of the fetus.

Global market of the intrapartum monitors is anticipated to grow by a of  CAGR of 8.1% during the forecast period 2016-2023. The trend affecting the intrapartum device market is the high use of the intrapartum monitors technology across the world. In intrapartum monitoring and management, devices used are fetal scalp electrode (FSE) and intrauterine pressure catheters (IUPC).IUPC is used to calculate the adequacy of the contradiction and when labor dystocia is concern Montevideo is frequently used. For the detailed visualization of pregnancy structure and of fetus in utero MRI system is highly used. MRI is owed to the use of the fast sequence as it is an interactive scanning system. In conclusion it is said that in the coming years there will sharp increase in the market due to increase in the use of the Intrapartum technology such as ultrasonic device, MRI fetal system, fetal pulse oximeter etc. MRI is owed to the use of the fast sequence as it is an interactive scanning system. In conclusion it is said that in the coming years there will sharp increase in the market due to increase in the use of the Intrapartum technology such as ultrasonic device, MRI fetal system, fetal pulse oximeter etc  The global intrapartum device market is primarily driven by following factors:

  • Increase rate of birth and preterm birth
  • Rising government and non-government initiatives
  • Technological Advancement
  • Increasing Company Investment





Key driver of the market are increasing rate of the birth and preterm birth. According to the world health organization statistics every year 15 million baby are born preterm that is before completing the gestation period of 37 weeks and the number is raising. This has become leading cause of the death of the children under 5 years. The preterm birth was cause of the 1 million deaths in 2015. According to the world health organization rate of preterm birth ranges from 5% to 18% across the 184 countries. When the baby is born before 37 weeks it is called preterm birth. The preterm has sub categories which is based on the gestational period age they are following, if birth is between the moderate to late that is( 32 to 37 weeks), very preterm (28 to 32 weeks), extremely preterm (less than 28 weeks). There has been rise in the death of the babies across the world which has raise the alarm to control this deaths. As WHO has determine the rate of the death of the babies which it has defined under the categories according to the number of weeks after in which baby was born. Government has taken the initiatives to control the preterm death. This will increase the market as large number of the equipment will be purchased by the government. Other than this developing countries will be large market as the medical system is been upgraded in the stage of the development. Apart from this high cost of the equipment and the stringent rules and regulation major factors hindering the global intrapartum device market. However the demand of portable and wireless product and growth through emerging market are creating an opportunity for intrapartum device market. Along with this high cost of equipment is one of the major challenge.

Source: OBRC Analysis

The global intrapartum device market segments includes by type and equipment’s.  

Type is further sub segmented into:

  • Ultrasound Device
  • Fetal Doppers
  • Fetal MRI System
  • Fetal Monitors
  • Fetal Oximeter






Equipment’s is further segmented into:

  • Infant Warmers
  • Incubators
  • Convertible Warmer and Incubators
  • Phototherapy Equipment
  • Respiratory Devices
  • Neonatal Monitoring Devices







The revenue for the above equipment’s are specific to the intrapartum device market. However, the total revenue of these equipment’s in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up type & equipment segment.

Geographically, the global intrapartum device   market has been segmented on the basis of four major region, which include:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America is anticipated to accounts the largest market share fastest growing region from 2016 to 2023, due to high awareness, dynamic lifestyle, rising obesity patients and delayed pregnancy. On the other hand, the. Asia-Pacific market is anticipated to the fastest-growing region for the intrapartum device market and also is anticipated to witness significant growth. This region has     some advantages through some other Asian countries such as India, China and Japan, which   leads to the growth of the intrapartum device market such as  high cases of premmies birth, increasing spending in healthcare segment, access to healthcare services, establishment of new diagnostic centers and improvement in healthcare infrastructure.

Segmentation of the intrapartum market is done on the basis type and equipment. Sub segment of the type is ultra sound device, fetal Dopplers, Fetal MRI system, fetal monitors, fetal pulse oximeters. Segmentation on the basis of the equipment are infant warmers, incubators, convertible warmers and incubators, phototherapy equipment, respiratory device neonatal monitoring. Fetal Doppler are made up of ultrasound scan which used to assess the health of the baby such as brain, heart and umbilical cord.It helps to check weather child is getting proper nutrient and oxygen. A Doppler is used as normal ultrasound system, it is easy to use as it can be operated by the practitioner also. Sound waves comes out the transducer, this sound waves bounce back to through blood circulation system and via the cord of the baby. By this an image is created on the screen which shows how the internal system which is blood system, cord is working. Doctors refers dopplar scan when there  are twins or more, when baby is affected with slap cheeked syndrome, when rhesus antibodies has affected the baby, baby is not growing  healthy, recently has miscarriage, rate of growing of the baby is very low, there has been some medical condition with the mother such as high blood pressure and diabetes. If mother smoke or have low and high BMI.

The major market players of the global intrapartum device market are:

  • ATOM MEDICAL COOPERATION
  • BECTON DICKSON AND COMPANY
  • GE HEALTHCARE
  • PHOENIX MEDICAL SYSTEM
  • NEOVENATA MEDICAL AB
  • OTHERS







These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching. Example May 2017 Fisher & Paykel Healthcare launched New Infant Cannula with innovative Wave flex technology. Due to this new technology the cannula can flex with the facial movements while delivering therapy. It supports in keeping the nasal prongs securely in place while treatment. Due to this innovation the product will cover a wider range of patients by the introduction of an extra small size that can fit smaller babies down to 0.5kg. Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

Why to buy the report:

This report will provide you:

  • Provide you the business strategies adopted by market player such as product launch that is on May 2017 Fisher & Paykel Healthcare launched New Infant Cannula.
  • Provide in detail the different segments such as by products and end-users which are affecting the global intrapartum device market.
  • Provide you the patent analysis of the intrapartum device market.
  • Identify, understand, and the strength, opportunities, challenges and threat of the   intrapartum device market.
  • Provide revenues of major players of the market such as Becton Dickson And Company, Atom Medical Cooperation.
  • Provide you various the regulatory policies which are affecting the global intrapartum device market.







How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global intrapartum device market offers the longest chain of market segmentation covering major market segmentation based on products and end users. The report tracks the major market trends in the global intrapartum device market such as high use of the intrapartum monitors technology across the world.  For each market segments covered in global intrapartum device market report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the   intrapartum device industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key Findings of the global intrapartum device market:

  • Increasing rate of the birth and preterm birth is fueling growth in global intrapartum device market.
  • North America is anticipated to account the largest revenue share in 2016.
  • Fetal monitoring devices  segment is the dominating market due to high use of fetal monitors in diagnosing severe conditions such as hypoxic ischemia, cerebral palsy etc.
  • Product launch is the key strategy adopted by the various market players of global intrapartum device market.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL   INTRAPARTUM DEVICES MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION AND SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE &TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. INCREASE RATE OF BIRTH AND PRETERM BIRTH
3.1.2. RISING GOVERNMENT AND NON-GOVERNMENT INITIATIVES
3.1.3. TECHNOLOGICAL ADVANCEMENT
3.1.4. INCREASING COMPANY INVESTMENT
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST OF THE EQUIPMENT
3.2.2. STRINGENT RULES AND REGULATION
3.3. MARKET OPPORTUNITIES
3.3.1. PORTABLE AND WIRELESS PRODUCT
3.3.2. EMERGING MARKET
3.4.  MARKET CHALLENGES 
3.4.1. HIGH COST OF THE EQUIPMENT
3.4.2. HIGH COMPETITION AMONG THE MARKET PLAYER
 
4. MARKET SEGMENTATION 
4.1. GLOBAL   INTRAPARTUM DEVICE S MARKET BY TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL ULTRAOUND DEVICE MARKET 
4.1.5.1.1. APPLICATIONS
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. GLOBAL FETAL DOPPERS MARKET 
4.1.5.2.1. APPLICATIONS
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.3. GLOBAL FETAL MRI SYSTEM MARKET 
4.1.5.3.1. APPLICATIONS
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5. KEY CONCLUSIONS
 
4.1.5.4. GLOBAL  FETAL MONITORS MARKET 
4.1.5.4.1. APPLICATIONS
4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.4.5. KEY CONCLUSIONS
 
4.1.5.5. GLOBAL FETAL OXIMETER MARKET 
4.1.5.5.1. APPLICATIONS
4.1.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.5.5. KEY CONCLUSION
4.2. GLOBAL   INTRAPARTUM DEVICE SMARKET BY EQUIPMENT 
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL INFANT WARMERS MARKET 
4.2.5.1.1. APPLICATIONS
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL INCUBATORS MARKET
4.2.5.2.1. APPLICATIONS
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL CONVERIBLE WARMER AND ICUBATORS MARKET 
4.2.5.3.1. APPLICATIONS
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL PHOTOTHERAPY EQUIPMENT MARKET 
4.2.5.4.1. APPLICATIONS
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.2.5.5. GLOBAL RESPIRATORY DEVICES MARKET 
4.2.5.5.1. APPLICATIONS
4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.5.5. KEY CONCLUSIONS
4.2.5.6. GLOBAL  NEONATAL MONITORING DEVICES MARKET 
4.2.5.6.1. APPLICATIONS
4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.6.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION 
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GLOBAL   INTRAPARTUM DEVICE SMARKET BY REGION 
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. ITALY 
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1.  ATOM MEDICAL COOPERATION
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION/FOCUS SECTOR
7.1.4. STRATEGIC INITIATIVES 
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. BECTON DICKSON AND COMPANY
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION/FOCUS SECTOR
7.2.4. STRATEGIC INITIATIVES 
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
 
7.3. CORPORATION SURGICAL INC
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION/FOCUS SECTOR
7.3.4. STRATEGIC INITIATIVES 
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS 
7.4. EADEN INSTRUMENT INC
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION/FOCUS SECTOR
7.4.4. STRATEGIC INITIATIVES 
7.4.5. SCOT ANALYSIS 
7.4.6. STRATEGIC ANALYSIS
 
7.5. FISHER AND PAYKEL HEALTHCARE COOPERATION LIMITED
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION/FOCUS SECTOR
7.5.4. STRATEGIC INITIATIVES 
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
 
7.6. GE HEALTHCARE
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION/FOCUS SECTOR
7.6.4. STRATEGIC INITIATIVES 
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. MASIMO CORPORATION
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION/FOCUS SECTOR
7.7.4. STRATEGIC INITIATIVES 
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
 
 
7.8. MEDIANA CO PRIVATE LIMITED
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION/FOCUS SECTOR
7.8.4. STRATEGIC INITIATIVES 
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. MEDITRONCS PUBLIC LIMITED COMPANY
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION/FOCUS SECTOR
7.9.4. STRATEGIC INITIATIVES 
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. NATUS MEDICAL INC
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION/FOCUS SECTOR
7.10.4. STRATEGIC INITIATIVES 
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11.    NEOVENATA MEDICAL AB
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION/FOCUS SECTOR
7.11.4. STRATEGIC INITIATIVES 
7.11.5. SCOT ANALYSIS 
7.11.6. STRATEGIC ANALYSIS
7.12. PHOENIX MEDICAL SYSTEM
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION/FOCUS SECTOR
7.12.4. STRATEGIC INITIATIVES 
7.12.5. SCOT ANALYSIS 
7.12.6. STARTEGIC ANALYSIS
7.13. PHILIPS HEALTHCARE
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION/FOCUS SECTOR
7.13.4. STRATEGIC INITIATIVES 
7.13.5. SCOT ANALYSIS 
7.13.6. STARTEGIC ANALYSIS
7.14. SPACELABS  HEALTHCARE
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION/FOCUS SECTOR
7.14.4. STRATEGIC INITIATIVES 
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS 
7.15. WALLACH SURGICAL DEVICES
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION/FOCUS SECTOR
7.15.4. STRATEGIC INITIATIVES 
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL   INTRAPARTUM DEVICE SMARKET BY TYPE 2014-2023($ MILLION)
2. GLOBAL ULTRAOUND DEVICE MARKET  BY GEOGRAPHY2014-2023($ MILLION)
3. GLOBAL FETAL DOPPERS MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
4. GLOBAL FETAL MRI SYSTEM MARKET BY GEOGRAPHY 2014-2023($ MILLION)
5. )
6. GLOBAL FETAL MONITORS  MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
7. GLOBAL  FETAL OXIMETER MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
8. GLOBAL   INTRAPARTUM DEVICE SMARKET BY EQUIPOMENT 2014-2023($ MILLION)
9. GLOBAL INFANT WARMERS MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
10. GLOBAL INCUBATORS MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
11. GLOBAL CONVERIBLE WARMER AND INCUBATORS  MARKET BY GEOGRAPHY 2014-2023($ MILLION)
12. GLOBAL PHOTOTHERAPY EQUIPMENT MARKET   BY GEOGRAPHY 2014-2023($ MILLION)
13. GLOBAL    RESPIRATORY DEVICES MARKET BY GEOGRAPHY 2014-2023($ MILLION)
14. GLOBAL NEONATAL MONITORING DEVICES MARKET BY GEOGRAPHY 2014-2023($ MILLION)
15. NORTH AMERICA   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
16. EUROPE   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
17. ASIA PACIFIC   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
18. REST OF THE WORLD   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
 
LIST OF FIGURES
 
1. GLOBAL   INTRAPARTUM DEVICE SMARKET BY ULTRAOUND DEVICE 2014-2023($ MILLION)
2. GLOBAL   INTRAPARTUM DEVICE SMARKET BY FETAL DOPPERS  2014-2023 ($ MILLION)
3. GLOBAL   INTRAPARTUM DEVICE SMARKET BY FETAL MRI SYSTEM 2014-2023 ($ MILLION)
4. GLOBAL   INTRAPARTUM DEVICE SMARKET BY  FETAL MONITORS 2014-2023 ($ MILLION)
5. GLOBAL   INTRAPARTUM DEVICE SMARKET BY  FETAL OXIMETER 2014-2023 ($ MILLION)
6. GLOBAL   INTRAPARTUM DEVICE SMARKET BY INFANT WARMERS 2014-2023 ($ MILLION)
7. GLOBAL   INTRAPARTUM DEVICE SMARKET BY INCUBATORS   2014-2023 ($ MILLION)
8. GLOBAL   INTRAPARTUM DEVICE SMARKET BY CONVERIBLE WARMER AND INCUBATORS 2014-2023 ($ MILLION)
9. GLOBAL   INTRAPARTUM DEVICE SMARKET BY PHOTOTHERAPY EQUIPMENT  2014-2023 ($ MILLION)
10. GLOBAL   INTRAPARTUM DEVICE SMARKET BY RESPIRATORY DEVICES 2014-2023 ($ MILLION)
11. GLOBAL   INTRAPARTUM DEVICE SMARKET BY  NEONATAL MONITORING DEVICES 2014-2023 ($ MILLION)
12. GLOBAL   INTRAPARTUM DEVICE SMARKET BY  PHOTOTHERAPY EQUIPMENT  2014-2023 ($ MILLION)
13. GLOBAL   INTRAPARTUM DEVICE SMARKET BY RESPIRATORY DEVICES 2014-2023 ($ MILLION)
14. GLOBAL   INTRAPARTUM DEVICE SMARKET BY NEONATAL MONITORING DEVICES   2014-2023 ($ MILLION)
15. UNITED STATES (U.S.)   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
16. CANADA   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
17. UNITED KINGDOM (UK)   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
18. FRANCE   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
19. GERMANY   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
20. SPAIN   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
21. ITALY   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
22. ROE   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
23. INDIA   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
24. CHINA   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
25. JAPAN   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
26. KOREA   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
27. AUSTRALIA   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
28. ROW APAC   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
29. LATIN AMERICA   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)
30. MENA   INTRAPARTUM DEVICE SMARKET2014-2023 ($MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

Go To Top
viewthroughconversion